ESC Premium Access

Intensive platelet inhibition - Have we reached the ceiling or are there options for further development?


About the speakers

Professor Lars Wallentin

Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala (Sweden)
14 presentations
0 follower

Professor Robert Storey

Department of Cardiovascular Science, University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
17 presentations
1 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Stefan James

Uppsala University, UCR-Uppsala Clinical Research Center, Uppsala (Sweden)
32 presentations
0 follower

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
29 presentations
1 follower

5 more presentations in this session

Welcome and Introduction

Speaker: Professor L. Wallentin (Uppsala, SE)


Manipulating the platelet - Successes and failures

Speaker: Professor R. Storey (Sheffield, GB)


Changing clinical outcomes with more intensive platelet inhibition

Speaker: Professor C. Cannon (Boston, US)


Effects in various clinical settings, patient subsets and healthcare realities

Speaker: Professor S. James (Uppsala, SE)


Summary and close

Speaker: Professor R. Mehran (New York, US)


Access the full session

Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results? (EBAC Accredited)

Speakers: Professor L. Wallentin, Professor R. Storey, Professor C. Cannon, Professor S. James, Professor R. Mehran...

About the event



31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk